Multiple Myeloma Coverage From Every Angle

MCRI Provides Funding for Novel Multiple Myeloma Research

By: Sarah Jackson
Posted: Thursday, December 7, 2017

The first patient-led crowdfunding initiative for research in multiple myeloma has raised more than $500,000 to explore new treatments for high-risk patients. The Myeloma Crowd Research Initiative (MCRI) is a novel approach to identifying and funding cancer research; it joins myeloma specialists with patient advocates and community leaders.

The MCRI is led by Myeloma Crowd, a division of the CrowdCare Foundation, which is a patient-driven, nonprofit organization. The MCRI received 36 research proposals from investigators worldwide and assembled a list of the top 10.

The first two projects selected for funding are a study of chimeric antigen receptor T-cell therapy targeting CS1 and BCMA, led by Hermann Einsele, MD, and Michael Hudecek, MD, both of the University of Würzburg, Germany, and a study of T-cell therapy with autologous transplant, led by Ivan Borrello, MD, of Johns Hopkins Sidney Kimmel Comprehensive Cancer Center.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.